Skip to main content
. 2020 Jan 13;15(1):e0227688. doi: 10.1371/journal.pone.0227688

Table 4. GP management of RC related shoulder pain by time period (2000–2016).


2000–2004
N = 1190
(95% CIs)
2004–2008
N = 1347
(95% CIs)
2008–2012
N = 1685
(95% CIs)
2012–2016
N = 2064
(95% CIs)
Management rate
(per 1000 encounters)
2.98
(2.78–3.19)
3.50
(3.26–3.73)
4.28
(4.03–5.52)
5.30
(5.02–5.57)
Medication 57.1 (54.0–60.1) 47.9 (44.9–50.8) 51.0 (48.5–53.6) 54.3 (52.0–56.6)
    NSAID 33.6 (30.7–36.5) 22.9 (20.4–25.3) 20.5 (18.4–22.5) 18.4 (16.7–20.1)
    Steroid–Injection 9.8 (7.9–11.8) 10.3 (8.3–12.3) 15.8 (13.9–17.8) 19.7 (17.8–21.6)
    Opioid 6.6 (5.2–8.1) 6.9 (5.5–8.3) 7.5 (6.2–8.8) 8.1 (6.9–9.3)
    Panadol 7.1 (5.6–8.6) 6.7 (5.3–8.1) 7.0 (5.8–8.2) 7.4 (6.1–8.6)
    Steroid–oral 0.2 (-0.1–0.4) 0.4 (-0.0–0.8) 0.1 (-0.0–0.3) 0.5 (0.2–0.8)
Advice/education/counselling 13.1 (11.1–15.1) 11.4 (9.6–13.3) 11.6 (10.0–13.2) 9.9 (8.5–11.4)
    Exercise 2.5 (1.6–3.4) 1.9 (1.1–2.7) 2.3 (1.6–3.0) 0.6 (0.2–0.9)
    Medication 0.8 (0.3–1.2) 0.4 (0.1–0.8) 0.4 (0.1–0.6) 0.6 (0.3–0.1)
Procedure 25.3 (22.6–28.0) 24.3 (21.3–27.2) 21.3 (18.9–23.7) 17.0 (15.1–18.9)
    Physical medicine/ rehabilitation 12.0 (10.0–14.0) 8.7 (6.9–10.5) 7.5 (6.2–8.9) 6.6 (5.4–7.8)
Referral 18.7 (16.5–21.0) 18.2 (16.0–20.4) 18.8 (16.8–20.7) 19.3 (17.4–21.1)
    Physiotherapist 10.6 (8.8–12.4) 11.5 (9.7–13.3) 11.2 (9.6–12.9) 12.2 (10.7–13.8)
    Surgeon 6.1 (4.7–7.6) 4.4 (3.3–5.5) 5.2 (4.1–6.2) 4.5 (3.6–5.4)
    Rheumatologist 1.3 (0.7–2.0) 0.6 (-0.1–1.2) 0.5 (0.1–0.8) 0.3 (0.1–0.6)
Imaging 24.2 (21.7–26.7) 27.2 (24.7–29.8) 35.5 (33.0–37.9) 44.1 (41.8–46.4)
    Ultrasound shoulder 19.1 (16.8–21.4) 24.2 (21.7–26.7) 33.1 (30.7–35.5) 41.9 (39.6–44.2)
    X-ray shoulder 13.7 (11.6–15.8) 12.1 (10.3–13.9) 12.2 (10.6–13.9) 11.8 (10.3–13.2)
    MRI shoulder 0.0 0.0 0.1 (-0.0–0.3) 0.5 (0.2–0.8)
    CT scan shoulder 0.0 0.0 0.3 (0.0–0.6) 0.1 (0.0–0.2)